Search research articles
Contact Us
Filters
Showing results (81-90 of 124) with videos related to
Page
of 13
Sort By:
Nature
|
December 13, 2006
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics
Julia E Aledort, Allan Ronald, Sylvie M Le Blancq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 2019
Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis
Godfather Dickson Kimaro, Lorna Guinness, Tinevimbo Shiri, et al.
Plos One
|
September 12, 2009
Implications of storing urinary DNA from different populations for molecular analyses
Angela Cannas, Glendah Kalunga, Clare Green, et al.
Lancet (London, England)
|
March 14, 2015
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
Sayoki Mfinanga, Duncan Chanda, Sokoine L Kivuyo, et al.
Lancet (London, England)
|
November 2, 2013
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
Grant Theron, Lynn Zijenah, Duncan Chanda, et al.
The Lancet. Infectious Diseases
|
March 28, 2018
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi, Nelita du Plessis, Gerhard Walzl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2012
Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic
Justin O'Grady, Matthew Bates, Lophina Chilukutu, et al.
Plos One
|
August 1, 2012
Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients
Matthew Bates, Justin O'Grady, Peter Mwaba, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 24, 2021
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa
Jean B Nachega, Nathan Kapata, Nadia A Sam-Agudu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Marco Schito, Giovanni Battista Migliori, Helen A Fletcher, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 124) with videos related to
Sort By:
Page
of 13
Nature
|
December 13, 2006
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics
Julia E Aledort, Allan Ronald, Sylvie M Le Blancq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 2019
Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis
Godfather Dickson Kimaro, Lorna Guinness, Tinevimbo Shiri, et al.
Plos One
|
September 12, 2009
Implications of storing urinary DNA from different populations for molecular analyses
Angela Cannas, Glendah Kalunga, Clare Green, et al.
Lancet (London, England)
|
March 14, 2015
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
Sayoki Mfinanga, Duncan Chanda, Sokoine L Kivuyo, et al.
Lancet (London, England)
|
November 2, 2013
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
Grant Theron, Lynn Zijenah, Duncan Chanda, et al.
The Lancet. Infectious Diseases
|
March 28, 2018
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi, Nelita du Plessis, Gerhard Walzl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 19, 2012
Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic
Justin O'Grady, Matthew Bates, Lophina Chilukutu, et al.
Plos One
|
August 1, 2012
Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients
Matthew Bates, Justin O'Grady, Peter Mwaba, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 24, 2021
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa
Jean B Nachega, Nathan Kapata, Nadia A Sam-Agudu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Marco Schito, Giovanni Battista Migliori, Helen A Fletcher, et al.
Page
of 13